30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Systemic lupus erythematosus (SLE) is associated with significant impairment of health-related quality of life (HR-QoL). Recently, meeting a definition of a lupus low disease activity state (LLDAS), analogous to low disease activity in rheumatoid arthritis, was preliminarily validated as associated with protection from damage accrual. The LLDAS definition has not been previously evaluated for association with patient-reported outcomes. The objective of this study was to determine whether LLDAS is associated with better HR-QoL, and examine predictors of HR-QoL, in a large multiethnic, multinational cohort of patients with SLE.

          Methods

          HR-QoL was measured using the Medical Outcomes Study 36-item short form health survey (SF-36v2) in a prospective study of 1422 patients. Disease status was measured using the SLE disease activity index (SLEDAI-2 K), physician global assessment (PGA) and LLDAS.

          Results

          Significant differences in SF-36 domain scores were found between patients stratified by ethnic group, education level and damage score, and with the presence of active musculoskeletal or cutaneous manifestations. In multiple linear regression analysis, Asian ethnicity ( p < 0.001), a higher level of education ( p < 0.001), younger age ( p < 0.001) and shorter disease duration ( p < 0.01) remained significantly associated with better physical component scores (PCS). Musculoskeletal disease activity ( p < 0.001) was negatively associated with PCS, and cutaneous activity ( p = 0.04) was negatively associated with mental component scores (MCS). Patients in LLDAS had better PCS ( p < 0.001) and MCS ( p < 0.001) scores and significantly better scores in multiple individual SF-36 domain scores. Disease damage was associated with worse PCS ( p < 0.001), but not MCS scores.

          Conclusions

          Ethnicity, education, disease damage and specific organ involvement impacts HR-QoL in SLE. Attainment of LLDAS is associated with better HR-QoL.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s13075-017-1256-6) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?

          Comparison of health related quality of life (HRQOL) of patients with systemic lupus erythematosus (SLE) with other common chronic illnesses. Responses from self-administered Medical Outcomes Study Short Form-36 (SF-36) questionnaires from 90 patients with SLE, recorded in the lupus database at the University of Chicago Hospital, were analyzed. Comparative norms and domain scores for patients with other chronic diseases [hypertension, congestive heart failure (CHF), adult onset diabetes mellitus, myocardial infarction, and depression] were used and are based on the general US population. T tests were used to make comparisons. Patients with SLE were younger than patients with most reference chronic conditions except for depression. Their Physical Component Scores and Mental Component Scores were 30 +/- 10.5 and 45.1 +/- 11, respectively. SLE patients fared significantly worse than age matched norms from the general US population for women (p = 0.0001) in all 8 domains. Their quality of life was significantly worse than for those with hypertension, diabetes, or myocardial infarction in all domains (p < 0.004). Patients with CHF were no worse than those with SLE in regard to physical function, role-physical, role-emotional, and vitality. CHF patients fared significantly better in mental health, bodily pain, social functioning, and general health, compared to patients with SLE. Patients with depression were significantly impaired in role-emotional and mental health domains (p = 0.0001) compared to SLE patients, but were no worse (role-physical, vitality, and social functioning) and even better (physical function, bodily pain, and general health) in some. General health of SLE patients was significantly lower than all comparative groups. HRQOL of patients with SLE seems to be significantly worse and affects all health domains at an earlier age in comparison to patients with some other common chronic diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Classification and definition of major flares in SLE clinical trials.

            Multiple reliable and valid disease activities indices exist and have been used successfully in longitudinal studies. However, the definition of flare, using these intruments, has not been universally decided or accepted. Because flare is one of the three major patterns of lupus activity, it will remain an important outcome measure in both longitudinal and clinical trial studies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort

              We describe disease activity, damage, and the accrual of key autoantibodies in an inception systemic lupus erythematosus (SLE) cohort.
                Bookmark

                Author and article information

                Contributors
                + 61 3 9594 5525 , vera.golder@monash.edu
                rangi.kandane-rathnayake@monash.edu
                alberta.hoi@monash.edu
                Molla.huq@unimelb.edu.au
                wlouthre@gmail.com
                anyfield@163.com
                zgli99@aliyun.com
                lsf00076@adm.cgmh.org.tw
                sargunan@um.edu.my
                cslau@hku.hk
                temy@hku.hk
                Aisha_LATEEF@nuhs.edu.sg
                kate.franklyn@monash.edu
                susan.morton@monashhealth.org.au
                Sandra_navarra@yahoo.com
                docleozamora@gmail.com
                yjwu1962@gmail.com
                hamijoyo@yahoo.com
                madelynn_chan@ttsh.com.sg
                Sean.ONeill@sswahs.nsw.gov.au
                Fiona.Goldblatt@health.sa.gov.au
                m.nikpour@unimelb.edu.au
                Eric.Morand@monash.edu
                Journal
                Arthritis Res Ther
                Arthritis Res. Ther
                Arthritis Research & Therapy
                BioMed Central (London )
                1478-6354
                1478-6362
                20 March 2017
                20 March 2017
                2017
                : 19
                : 62
                Affiliations
                [1 ]Monash University School of Clinical Sciences at Monash Health, Level 5, Block E, Monash Medical Centre, 246 Clayton Road, Clayton, VIC 3168 Melbourne, Australia
                [2 ]ISNI 0000 0001 2179 088X, GRID grid.1008.9, , The University of Melbourne, ; Melbourne, Australia
                [3 ]ISNI 0000 0004 0640 1251, GRID grid.470093.9, , Chiang Mai University Hospital, ; Chiang Mai, Thailand
                [4 ]ISNI 0000 0001 2256 9319, GRID grid.11135.37, , People’s Hospital Peking University Health Sciences Center, ; Beijing, China
                [5 ]Chang Gung Memorial Hospital, Guishan Township, Taiwan
                [6 ]ISNI 0000 0001 2308 5949, GRID grid.10347.31, , University of Malaya, ; Kuala Lumpur, Malaysia
                [7 ]ISNI 0000000121742757, GRID grid.194645.b, , University of Hong Kong, ; Pokfulam, Hong Kong
                [8 ]ISNI 0000 0004 0621 9599, GRID grid.412106.0, , National University Hospital, ; Singapore, Republic of Singapore
                [9 ]ISNI 0000 0000 9295 3933, GRID grid.419789.a, , Monash Health, ; Melbourne, Australia
                [10 ]ISNI 0000 0004 0419 0374, GRID grid.412777.0, , University of Santo Tomas Hospital, ; Manila, Philippines
                [11 ]ISNI 0000 0004 1796 1481, GRID grid.11553.33, , University of Padjadjaran, ; Bandung, Indonesia
                [12 ]GRID grid.240988.f, , Tan Tock Seng Hospital, ; Singapore, Republic of Singapore
                [13 ]ISNI 0000 0004 4902 0432, GRID grid.1005.4, , University of New South Wales, ; Sydney, Australia
                [14 ]ISNI 0000 0004 0367 1221, GRID grid.416075.1, , Royal Adelaide Hospital, ; Adelaide, Australia
                Author information
                http://orcid.org/0000-0001-5691-4344
                Article
                1256
                10.1186/s13075-017-1256-6
                5359963
                28320433
                d618e0a5-834e-4efa-9347-8661664f05a2
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 4 December 2016
                : 9 February 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100000925, National Health and Medical Research Council;
                Award ID: APP1093545
                Award ID: APP1071735
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/http://dx.doi.org/10.13039/100004330, GlaxoSmithKline;
                Award ID: The Asia-Pacific Lupus Collaboration receives project support grants from GlaxoSmithKline, UCB, and Janssen
                Funded by: UCB
                Award ID: The Asia-Pacific Lupus Collaboration receives project support grants from GlaxoSmithKline, UCB, and Janssen
                Funded by: FundRef http://dx.doi.org/http://dx.doi.org/10.13039/100008897, Janssen Pharmaceuticals;
                Award ID: The Asia-Pacific Lupus Collaboration receives project support grants from GlaxoSmithKline, UCB, and Janssen
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2017

                Orthopedics
                systemic lupus erythematosus,health-related quality of life,patient-reported outcomes,treatment target,low disease activity

                Comments

                Comment on this article